Litmys, a life sciences commercial strategy consulting firm specializing in commercial readiness and adoption analytics, and PharmaACE, a global life sciences consulting and analytics firm, announced a strategic collaboration designed to help life sciences companies make more informed development, investment, and comm…
Research Solutions, a leading provider of SaaS and AI-powered scientific research tools, announces the largest deal in company history: an enterprise Scite agreement valued at $1 million with a Fortune 500 biopharmaceutical company. The agreement expands the customer's longstanding Article Galaxy relationship with a f…
Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd. announced that it has completed the acquisition of assets from BioXcel Therapeutics, Inc., including worldwide rights to BXCL501. BXCL501 is an investigational dexmedetomidine sublingual film under FDA review for at-home use i…
InMed Pharmaceuticals Inc. announced the completion of the previously disclosed merger between the Company and the privately held Mentari Therapeutics, Inc. The combined company will continue to operate under the name Mentari Therapeutics, Inc.. Immediately prior to the closing of the merger, the Company completed it…
Agilent Technologies Inc. announced the successful completion of its previously announced acquisition of Proscia®, a leading provider of digital-pathology software for clinical and life-sciences customers. Under the terms of the transaction, Agilent acquired Proscia for $240 million in cash at closing, with up to an a…
Abbott, the global healthcare leader, and Novo, a global leader in treatments for serious chronic diseases, announced an expanded strategic collaboration to increase access to originator semaglutide for people living with type 2 diabetes across Asia Pacific. Under the agreement, Abbott will commercialise Plosbrio® (se…
Zuellig Pharma, a leading healthcare solutions company in Asia, announced the strategic acquisition of a specialized clinical supply facility in Hangzhou, China, strengthening its clinical sourcing capabilities to better support domestic and international clinical trials. The Hangzhou facility holds a Drug Distributi…
Brise Pharmaceuticals Co., Ltd. provided an update on its exclusive license agreement with AbbVie, which the companies entered in 2024. Under the terms of the collaboration agreement, Brise is responsible for discovery efforts and AbbVie will lead global development and commercialization activities for two of Brise's …
Fresenius SE & Co. KGaA announced that it has entered an exclusive development agreement with WuXi Biologics, a leading global contract organization for research, development and manufacturing. WuXi Biologics brings proven large-scale biologics development and manufacturing capability, a track record across monocl…
The College of Healthcare Information Management Executives (CHIME) announced a strategic joint venture with ScaleHealth, Inc. to create ScaleHealth, powered by CHIME, LLC, a new innovation ecosystem designed to connect healthcare's most pressing challenges with the innovators, leaders, organizations, and partners cap…
Page 1 of 43